» Articles » PMID: 19447791

Antimicrobial and Antibiofilm Efficacy of Triclosan and DispersinB Combination

Overview
Date 2009 May 19
PMID 19447791
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The objectives of this study were to examine: (i) synergy of the combination of triclosan and DispersinB (DspB); (ii) in vitro efficacy and durability of triclosan + DspB-coated vascular catheters; and (iii) in vivo efficacy of triclosan + DspB-coated catheters compared with chlorhexidine-silver sulfadiazine (CH-SS)-coated and uncoated (control) vascular catheters in preventing colonization by Staphylococcus aureus.

Methods: We investigated the potential synergistic antimicrobial and antibiofilm activity of triclosan and DspB by biofilm assays. The in vitro antimicrobial efficacy of triclosan + DspB-coated catheters was determined by microbial colonization assays. Antimicrobial durability of the coated catheters was tested by soaking segments in bovine serum for 7 days and determining antimicrobial activity, and by a serial plate transfer method. The in vivo efficacy of triclosan + DspB-coated catheters compared with CH-SS-coated and uncoated catheters was assessed by subcutaneous implantation of segments in a rabbit model of S. aureus infection.

Results: The combination of triclosan and DspB showed synergistic antimicrobial and antibiofilm activity against S. aureus, Staphylococcus epidermidis and Escherichia coli, significantly reduced bacterial colonization (P < 0.05) and generally demonstrated a prolonged superior antimicrobial activity against clinical pathogens compared with CH-SS-coated catheters. Triclosan + DspB-coated and CH-SS-coated catheters exhibited equal in vivo efficacy (P <or= 0.05) in reducing colonization by S. aureus compared with uncoated catheters.

Conclusions: Catheters coated with the triclosan + DspB combination showed synergistic, broad-spectrum and durable antimicrobial activity. Furthermore, the in vivo efficacy of catheters coated with this unique antimicrobial/antibiofilm composition prompts clinical evaluation of such an innovative approach.

Citing Articles

Sophorolipid: An Effective Biomolecule for Targeting Microbial Biofilms.

Dhadwal S, Handa S, Chatterjee M, Banat I Curr Microbiol. 2024; 81(11):388.

PMID: 39367190 DOI: 10.1007/s00284-024-03892-6.


Dispersin B: The Quintessential Antibiofilm Enzyme.

Kaplan J, Sukhishvili S, Sailer M, Kridin K, Ramasubbu N Pathogens. 2024; 13(8).

PMID: 39204268 PMC: 11357414. DOI: 10.3390/pathogens13080668.


Poly--(1→6)--acetyl-D-glucosamine mediates surface attachment, biofilm formation, and biocide resistance in .

Kaplan J, Cywes-Bentley C, Pier G, Yakandawala N, Sailer M, Edwards M Front Microbiol. 2024; 15:1386017.

PMID: 38751716 PMC: 11094747. DOI: 10.3389/fmicb.2024.1386017.


An apparent lack of synergy between degradative enzymes against biofilms.

Ellis J, Rowley P MicroPubl Biol. 2024; 2024.

PMID: 38596361 PMC: 11002645. DOI: 10.17912/micropub.biology.001119.


Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms.

Ahsan A, Thomas N, Barnes T, Subramaniam S, Loh T, Joyce P Pharmaceutics. 2024; 16(3).

PMID: 38543290 PMC: 10975566. DOI: 10.3390/pharmaceutics16030396.